Skip to menu Skip to content Skip to footer

2007

Journal Article

Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans

Francis, Roslyn J., Byrne, Michael J., Van Der Schaaf, Agatha A., Boucek, Jan A., Nowak, Anna K., Phillips, Michael, Price, Richard, Patrikeos, Andrew P., Musk, A. William and Millward, Michael J. (2007). Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans. Journal of Nuclear Medicine, 48 (9), 1449-1458. doi: 10.2967/jnumed.107.042333

Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans

2006

Journal Article

A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug

Mayer, Astrid, Francis, Roslyn J., Sharma, Surinder K., Tolner, Berend, Springer, Caroline J., Martin, Jan, Boxer, Geoff M., Bell, James, Green, Alan J., Hartley, John A., Cruickshank, Clare, Wren, Julie, Chester, Kerry A. and Begent, Richard H. J. (2006). A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug. Clinical Cancer Research, 12 (21), 6509-6516. doi: 10.1158/1078-0432.CCR-06-0769

A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug